Article
Brochure
Executive Resource
Insight Hub
Ext. Publication
VideoMedical Journal – Houston Features Weaver’s Insights on Life Sciences Companies Going Public
Never miss a thing.
Sign up to receive our insights newsletter.
“For life sciences founders, going public may be about to get a lot easier,” was recently published in the August edition of Medical Journal – Houston.
Written by David Lange, the article explores how a proposed Securities and Exchange Commission (SEC) rule could reduce compliance burdens for emerging growth companies and make public markets a more attractive option for life sciences organizations seeking capital.
“Many life sciences companies that succeed will face a decision about whether or not to go public. In theory it should be an easy call, since the public markets offer the deepest and cheapest pool of capital a growing company can reach. Yet over the past twenty years, more and more founders have hesitated. The reason has had less to do with the appeal than with the price of being public.”
©2026
